Paul Visintainer to Lyme Disease
This is a "connection" page, showing publications Paul Visintainer has written about Lyme Disease.
Connection Strength
6.309
-
Wormser GP, McKenna D, Morgan T, Scavarda C, Cooper D, Visintainer P. A Prospective Study to Characterize Symptoms and Symptom Severity in Adult Patients with Extracutaneous Manifestations of Lyme Disease. Am J Med. 2023 07; 136(7):702-706.
Score: 0.766
-
Wormser GP, Warshafsky S, Visintainer P. Postexposure prophylaxis with single-dose doxycycline is effective for prevention of Lyme disease in both the United States and Europe and is also effective for prevention of syphilis and tick-borne relapsing fever. Diagn Microbiol Infect Dis. 2021 07; 100(3):115367.
Score: 0.662
-
Wormser GP, McKenna D, Shaffer KD, Silverman JH, Scavarda C, Visintainer P. Evaluation of selected variables to determine if any had predictive value for, or correlated with, residual symptoms at approximately 12 months after diagnosis and treatment of early Lyme disease. Diagn Microbiol Infect Dis. 2021 Jul; 100(3):115348.
Score: 0.659
-
Wormser GP, McKenna D, Jacobson E, Shanker EM, Shaffer KD, Scavarda C, Visintainer P. Patients with Erythema Migrans: Characterizing the Impact of Initiation of Antibiotic Therapy Prior to Study Enrollment. Antimicrob Agents Chemother. 2020 12 16; 65(1).
Score: 0.652
-
Wormser GP, McKenna D, Karmen CL, Shaffer KD, Silverman JH, Nowakowski J, Scavarda C, Shapiro ED, Visintainer P. Prospective Evaluation of the Frequency and Severity of Symptoms in Lyme Disease Patients With Erythema Migrans Compared With Matched Controls at Baseline, 6 Months, and 12 Months. Clin Infect Dis. 2020 12 15; 71(12):3118-3124.
Score: 0.652
-
Wormser GP, Warshafsky S, Visintainer P. Aggregation of data from 4 clinical studies demonstrating efficacy of single-dose doxycycline postexposure for prevention of the spirochetal infections: Lyme disease, syphilis, and tick-borne relapsing fever. Diagn Microbiol Infect Dis. 2021 Apr; 99(4):115293.
Score: 0.652
-
Wormser GP, Sudhindra P, Lopez E, Patel L, Rezai S, Brumbaugh AD, McKenna D, Scavarda C, Shapiro ED, Karmen CL, Visintainer P. Fatigue in patients with erythema migrans. Diagn Microbiol Infect Dis. 2016 Nov; 86(3):322-326.
Score: 0.481
-
Wormser GP, Weitzner E, Dornbush R, Visintainer P. Reply to Greenberg. Clin Infect Dis. 2015 Dec 01; 61(11):1765-6.
Score: 0.450
-
Wormser GP, Weitzner E, Dornbush R, Visintainer P. Reply to Crawford. Clin Infect Dis. 2015 Oct 01; 61(7):1209-10.
Score: 0.446
-
Weitzner E, Visintainer P, Wormser GP. Impact of patient age on clinical features, serologic test reactivity and long-term outcome of culture-confirmed early Lyme disease. Diagn Microbiol Infect Dis. 2017 Dec; 89(4):300-302.
Score: 0.130
-
Ogrinc K, Wormser GP, Visintainer P, Maraspin V, Lotric-Furlan S, Cimperman J, Ru?ic-Sabljic E, Bogovic P, Rojko T, Stupica D, Strle F. Pathogenetic implications of the age at time of diagnosis and skin location for acrodermatitis chronica atrophicans. Ticks Tick Borne Dis. 2017 02; 8(2):266-269.
Score: 0.123
-
Weitzner E, Visintainer P, Wormser GP. Comparison of males versus females with culture-confirmed early Lyme disease at presentation and at 11-20 years after diagnosis. Diagn Microbiol Infect Dis. 2016 Aug; 85(4):493-5.
Score: 0.118
-
Weitzner E, McKenna D, Nowakowski J, Scavarda C, Dornbush R, Bittker S, Cooper D, Nadelman RB, Visintainer P, Schwartz I, Wormser GP. Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease. Clin Infect Dis. 2015 Dec 15; 61(12):1800-6.
Score: 0.113
-
Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Molla I, Dornbush R, Visintainer P, Nowakowski J. Long-term assessment of health-related quality of life in patients with culture-confirmed early Lyme disease. Clin Infect Dis. 2015 Jul 15; 61(2):244-7.
Score: 0.110
-
Wormser GP, Tang AT, Schimmoeller NR, Bittker S, Cooper D, Visintainer P, Aguero-Rosenfeld ME, Ogrinc K, Strle F, Stanek G. Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa. Med Microbiol Immunol. 2014 Feb; 203(1):65-71.
Score: 0.100
-
Nowakowski J, McKenna D, Nadelman RB, Bittker S, Cooper D, Pavia C, Holmgren D, Visintainer P, Wormser GP. Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United States. Clin Infect Dis. 2009 Dec 01; 49(11):1733-5.
Score: 0.076
-
Wormser GP, Nowakowski J, Nadelman RB, Visintainer P, Levin A, Aguero-Rosenfeld ME. Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease. Clin Vaccine Immunol. 2008 Oct; 15(10):1519-22.
Score: 0.069
-
Wormser GP, Ramanathan R, Nowakowski J, McKenna D, Holmgren D, Visintainer P, Dornbush R, Singh B, Nadelman RB. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2003 May 06; 138(9):697-704.
Score: 0.048